🇺🇸 FDA
Patent

US 11918627

Dosage regimen for inhaled vasoactive intestinal polypeptide

granted A61KA61K38/2278A61K9/0078

Quick answer

US patent 11918627 (Dosage regimen for inhaled vasoactive intestinal polypeptide) held by CENTURION ÌLAÇ SANAYI VE TICARET ANONIM SIRKETI expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CENTURION ÌLAÇ SANAYI VE TICARET ANONIM SIRKETI
Grant date
Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/2278, A61K9/0078, A61P, A61P11/00